Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery
ACS Applied Bio Materials · 2024
DOI: 10.1021/acsabm.4c01557 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Xinxin Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, PR China. Hauptthemen laut MEDLINE: Cryogels, Cancer Vaccines, Biocompatible Materials. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, PR China.
- Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (People's Hospital of Hangzhou Medical College), Hangzhou, Zhejiang 310014, PR China.
ORCID-Profile: Jie Feng, Jing Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Luo, X., Ni, H., Lu, J., Feng, J., Mou, X., & Zhang, J. (2024). Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c01557
Vancouver
Luo X, Ni H, Lu J, Feng J, Mou X, Zhang J. Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c01557
BibTeX
@article{Luo2024,
author = {Luo, Xinxin and Ni, Haifeng and Lu, Jie and Feng, Jie and Mou, Xiaozhou and Zhang, Jing},
title = {Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery},
journal = {ACS Applied Bio Materials},
year = {2024},
doi = {10.1021/acsabm.4c01557}
}
EUVIMED